Omthera Pharmaceuticals
Princeton
About Omthera Pharmaceuticals
Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia. Led by a team of experts with exceptional experience in developing new therapies for lipid disorders, Omthera is dedicated to developing innovative therapies for the millions of patients who have elevated triglyceride levels and increased risk of cardiovascular disease.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $60.2M
- Funding stage: M&A
- Last round: Debt Financing (Feb 2013)
- Ticker: nasdaq:OMTH
- Website: omthera.com
- Phone: +1 908-741-4399
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/omthera-pharmaceuticals-1984345 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.